Kyverna Therapeutics (KYTX) Other Non-Current Assets (2023 - 2026)
Kyverna Therapeutics (KYTX) posted Other Non-Current Assets of $551000.0 for Q1 2026, down 88.76% on a QoQ basis from $4.9 million in Q4 2025, and down 84.88% year-over-year from $3.6 million in Q1 2025.
Kyverna Therapeutics (KYTX) Other Non-Current Assets (2023 - 2026) Analysis & Trends
Kyverna Therapeutics' Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $551000.0 for Q1 2026.
- Quarterly Other Non-Current Assets fell 84.88% year-over-year to $551000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $551000.0 (down 84.88% YoY) and the FY2025 annual result came in at $4.9 million, up 788.22% from the prior year.
- Other Non-Current Assets was $551000.0 for Q1 2026 at Kyverna Therapeutics, down from $4.9 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $4.9 million in Q4 2025 and bottomed at $551000.0 in Q3 2025.
- A 4-year average of $1.7 million and a median of $585000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2025 — Other Non-Current Assets soared 788.22% — and 2026, when it sank 84.88%.
- Kyverna Therapeutics' Other Non-Current Assets stood at $600000.0 in 2023, then declined by 8.0% to $552000.0 in 2024, then surged by 788.22% to $4.9 million in 2025, then plunged by 88.76% to $551000.0 in 2026.
- Business Quant data shows KYTX's Other Non-Current Assets at $551000.0 in Q1 2026, $4.9 million in Q4 2025, and $551000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Kyverna Therapeutics | 440.57 Mn | 440.57 Mn | - | 551,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 551,000.00 |
| Dec 31, 2025 | 4.90 Mn |
| Sep 30, 2025 | 551,000.00 |
| Jun 30, 2025 | 4.05 Mn |
| Mar 31, 2025 | 3.64 Mn |
| Dec 31, 2024 | 552,000.00 |
| Sep 30, 2024 | 564,000.00 |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 570,000.00 |
| Dec 31, 2023 | 600,000.00 |